Erbilen, EnverÖzhan, HakanAkdemir, RamazanYazıcı, Mehmet2021-06-232021-06-2320050172-06431432-1971https://doi.org/10.1007/s00246-004-0768-4https://hdl.handle.net/20.500.12491/5708Sumatriptan is widely used in the treatment of acute attacks of cluster headache. It is a serotonin-1 (5HT-1) agonist. Several studies have reported an association between sumatriptan use and myocardial infarction, possibly due to the generalized vasoconstrictive nature of this agent. We report a 16-year-old male patient presenting with acute inferior myocardial infarction after sumatriptan use without any known risk factors of coronary artery disease.eninfo:eu-repo/semantics/closedAccessSumatriptanMyocardial InfarctionArticle10.1007/s00246-004-0768-4264464466163746992-s2.0-29344434438Q2WOS:000232473000032Q3